CARA THERAPEUTICS INC (CARA) Stock Analyst Ratings
USA - NASDAQ:CARA - US1407552082 - Common Stock
5.32 USD
-0.23 (-4.14%)
5.43 USD
+0.11 (+2.07%)
ChartMill assigns a Buy % Consensus number of 43% to CARA. The Buy consensus is the weighted average rating of the current analysts ratings.
CARA was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about CARA.
In the previous month the buy percentage consensus was at a similar level.
CARA was analyzed by 6 analysts. More opinions would make the average more meaningful.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-06-13 | Needham | Downgrade | Buy -> Hold |
| 2024-06-13 | Canaccord Genuity | Downgrade | Buy -> Hold |
| 2024-06-13 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-05-23 | Needham | Reiterate | Buy -> Buy |
| 2024-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-14 | Needham | Reiterate | Buy -> Buy |
| 2024-04-10 | Needham | Reiterate | Buy -> Buy |
| 2024-03-28 | Needham | Reiterate | Buy -> Buy |
| 2024-03-06 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-03-05 | Needham | Reiterate | Buy -> Buy |
| 2024-01-22 | Needham | Maintains | Buy -> Buy |
| 2023-12-19 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-12-18 | Needham | Maintains | Buy -> Buy |
| 2023-11-14 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2023-10-19 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-08 | Needham | Reiterate | Buy -> Buy |
| 2023-08-08 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-06-27 | Stifel | Reiterate | Buy -> Buy |
| 2023-06-27 | Jefferies | Reiterate | Buy -> Buy |
| 2023-05-16 | Needham | Reiterate | Buy |
| 2023-05-16 | B of A Securities | Maintains | Underperform -> Underperform |
| 2023-05-16 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-04-18 | Needham | Reiterate | Action List Buy |
| 2023-04-04 | Needham | Reiterate | Buy |
| 2023-03-08 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2023-03-07 | Needham | Maintains | Buy |
| 2023-03-07 | JP Morgan | Maintains | Overweight |
| 2023-03-07 | Canaccord Genuity | Maintains | Buy |
| 2023-03-07 | Piper Sandler | Maintains | Overweight |
| 2023-03-07 | HC Wainwright & Co. | Maintains | Buy |
CARA THERAPEUTICS INC / CARA FAQ
Can you provide the consensus rating for CARA THERAPEUTICS INC stock?
The consensus rating for CARA THERAPEUTICS INC (CARA) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.